Literature DB >> 25281944

Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment.

Huijun Xu1, Douglas J Vile2, Manju Sharma2, J James Gordon3, Jeffrey V Siebers4.   

Abstract

PURPOSE: To compare two coverage-based planning (CP) techniques with standard fixed margin-based planning (FM), considering the dosimetric impact of interfraction deformable organ motion exclusively for high-risk prostate treatments.
METHODS: Nineteen prostate cancer patients with 8-13 prostate CT images of each patient were used to model patient-specific interfraction deformable organ changes. The model was based on the principal component analysis (PCA) method and was used to predict the patient geometries for virtual treatment course simulation. For each patient, an IMRT plan using zero margin on target structures, prostate (CTVprostate) and seminal vesicles (CTVSV), were created, then evaluated by simulating 1000 30-fraction virtual treatment courses. Each fraction was prostate centroid aligned. Patients whose D98 failed to achieve 95% coverage probability objective D98,95 ≥ 78 Gy (CTVprostate) or D98,95 ≥ 66 Gy (CTVSV) were replanned using planning techniques: (1) FM (PTVprostate = CTVprostate + 5 mm, PTVSV = CTVSV + 8 mm), (2) CPOM which optimized uniform PTV margins for CTVprostate and CTVSV to meet the coverage probability objective, and (3) CPCOP which directly optimized coverage probability objectives for all structures of interest. These plans were intercompared by computing probabilistic metrics, including 5% and 95% percentile DVHs (pDVH) and TCP/NTCP distributions.
RESULTS: All patients were replanned using FM and two CP techniques. The selected margins used in FM failed to ensure target coverage for 8/19 patients. Twelve CPOM plans and seven CPCOP plans were favored over the other plans by achieving desirable D98,95 while sparing more normal tissues.
CONCLUSIONS: Coverage-based treatment planning techniques can produce better plans than FM, while relative advantages of CPOM and CPCOP are patient-specific.

Entities:  

Mesh:

Year:  2014        PMID: 25281944      PMCID: PMC4290467          DOI: 10.1118/1.4894701

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  41 in total

1.  Algorithms and functionality of an intensity modulated radiotherapy optimization system.

Authors:  Q Wu; R Mohan
Journal:  Med Phys       Date:  2000-04       Impact factor: 4.071

2.  Dosimetric treatment course simulation based on a statistical model of deformable organ motion.

Authors:  M Söhn; B Sobotta; M Alber
Journal:  Phys Med Biol       Date:  2012-05-22       Impact factor: 3.609

3.  Variation in target and rectum dose due to prostate deformation: an assessment by repeated MR imaging and treatment planning.

Authors:  E M Kerkhof; R W van der Put; B W Raaymakers; U A van der Heide; M van Vulpen; J J W Lagendijk
Journal:  Phys Med Biol       Date:  2008-09-17       Impact factor: 3.609

4.  Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.

Authors:  Michel Ghilezan; Di Yan; Jian Liang; David Jaffray; John Wong; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

Review 5.  Adaptive radiation therapy for prostate cancer.

Authors:  Michel Ghilezan; Di Yan; Alvaro Martinez
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

6.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

Authors:  A Niemierko; M Goitein
Journal:  Radiother Oncol       Date:  1993-11       Impact factor: 6.280

7.  Modelling individual geometric variation based on dominant eigenmodes of organ deformation: implementation and evaluation.

Authors:  M Söhn; M Birkner; D Yan; M Alber
Journal:  Phys Med Biol       Date:  2005-12-06       Impact factor: 3.609

8.  A population-based model to describe geometrical uncertainties in radiotherapy: applied to prostate cases.

Authors:  E Budiarto; M Keijzer; P R Storchi; M S Hoogeman; L Bondar; T F Mutanga; H C J de Boer; A W Heemink
Journal:  Phys Med Biol       Date:  2011-01-21       Impact factor: 3.609

9.  A model to simulate day-to-day variations in rectum shape.

Authors:  Mischa S Hoogeman; Marcel van Herk; Di Yan; Liesbeth J Boersma; Peter C M Koper; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

10.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

Authors:  S Webb; A E Nahum
Journal:  Phys Med Biol       Date:  1993-06       Impact factor: 3.609

View more
  8 in total

1.  Erratum: "Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment" [Med. Phys. 41(10), 101705 (14pp.) (2014)].

Authors:  Huijun Xu; Douglas J Vile; Manju Sharma; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

2.  Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment.

Authors:  Huijun Xu; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

3.  Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer.

Authors:  Wei Liu; Samir H Patel; Jiajian Jason Shen; Yanle Hu; Daniel P Harrington; Xiaoning Ding; Michele Y Halyard; Steven E Schild; William W Wong; Gary A Ezzell; Martin Bues
Journal:  Pract Radiat Oncol       Date:  2016-02-13

Review 4.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

5.  Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer.

Authors:  Wei Liu; Samir H Patel; Daniel P Harrington; Yanle Hu; Xiaoning Ding; Jiajian Shen; Michele Y Halyard; Steven E Schild; William W Wong; Gary E Ezzell; Martin Bues
Journal:  J Appl Clin Med Phys       Date:  2017-05-14       Impact factor: 2.102

6.  A novel probabilistic approach to generating PTV with partial voxel contributions.

Authors:  H S Tsang; C P Kamerling; P Ziegenhein; S Nill; U Oelfke
Journal:  Phys Med Biol       Date:  2017-04-05       Impact factor: 3.609

7.  Performance evaluation of a newly developed three-dimensional model-based global-to-local registration in prostate cancer.

Authors:  Mitsuhiro Nakamura; Megumi Nakao; Hideaki Hirashima; Hiraku Iramina; Takashi Mizowaki
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

8.  Novel adaptive beam-dependent margins for additional OAR sparing.

Authors:  H S Tsang; C P Kamerling; P Ziegenhein; S Nill; U Oelfke
Journal:  Phys Med Biol       Date:  2018-10-29       Impact factor: 3.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.